Associations of statin use with glycaemic traits and incident type 2 diabetes.

Ahmadizar, Fariba; OchoaRosales, Carolina; Glisic, Marja; Franco, Oscar H; Muka, Taulant; Stricker, Bruno H (2019). Associations of statin use with glycaemic traits and incident type 2 diabetes. British journal of clinical pharmacology, 85(5), pp. 993-1002. Wiley-Blackwell 10.1111/bcp.13898

Ahmadizar BrJClinPharmacol 2019_AAM.pdf - Accepted Version
Available under License Publisher holds Copyright.

Download (587kB) | Preview
[img] Text
Ahmadizar BrJClinPharmacol 2019.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (843kB) | Request a copy


There are several epidemiological studies on the association between statins and incident diabetes, but most of them lack details. In this study, we aimed to investigate the association of statin use with glycaemic traits and incident type 2 diabetes.


Using the prospective population-based Rotterdam Study, we included 9,535 individuals free from diabetes at baseline (>45 years) during the study period between 1997 and 2012. Linear regression analysis was applied to examine the cross-sectional associations between statin use and glycaemic traits including fasting blood serum of glucose and insulin concentrations, and insulin resistance. In a longitudinal follow-up study, we applied a Cox regression analysis to determine adjusted hazard ratios (HR) for incident type 2 diabetes in new users of statins.


The mean age at baseline was 64.3±10.1 year and 41.7% were men. In the fully adjusted model, compared to never users of statins, baseline use of statins was associated with higher concentrations of serum fasting insulin (β, 0.07; 95% CI: 0.02-0.13) and insulin resistance (β, 0.09; 95% CI: 0.03-0.14). Ever use of statins was associated with a 38% higher risk of incident type 2 diabetes (HR, 1.38; 95% CI: 1.09-1.74). This risk was more prominent in subjects with impaired glucose homeostasis and in overweight/obese individuals.


Individuals using statins may be at higher risk for hyperglycaemia, insulin resistance and eventually type 2 diabetes. Rigorous preventive strategies such as glucose control and weight reduction in patients when initiating statin therapy might help minimizing the risk of diabetes.

Item Type:

Journal Article (Original Article)


04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Social and Preventive Medicine (ISPM)

UniBE Contributor:

Franco Duran, Oscar Horacio and Muka, Taulant


600 Technology > 610 Medicine & health
300 Social sciences, sociology & anthropology > 360 Social problems & social services








Andrea Flükiger-Flückiger

Date Deposited:

13 Mar 2019 13:20

Last Modified:

01 Jun 2020 02:30

Publisher DOI:


PubMed ID:


Uncontrolled Keywords:

Statins impaired fasting glucose insulin resistance type 2 diabetes mellitus




Actions (login required)

Edit item Edit item
Provide Feedback